As an association representing 104 leading academic cancer centers in the U.S. and Canada, AACI enjoys a longstanding relationship with NCI leadership.
“AACI prioritizes diversity, equity, and inclusion, particularly as they relate to the cancer center leadership pipeline and clinical trials,” said Caryn Lerman, PhD, AACI president and director of USC Norris Comprehensive Cancer Center. “We look forward to working with Dr. Bertagnolli to advance our common goals.”
Dr. Lerman also expressed AACI’s appreciation for the exceptional leadership of Drs. Norman E. Sharpless and Douglas R. Lowy, NCI’s former director and acting director.
AACI’s mission is to accelerate progress against cancer by enhancing the impact of North America’s leading academic cancer centers. For more information, please visit aaci-cancer.org.